Teva Pharmaceutical (TEVA) Stock Rating Cut at HSBC - TheStreet
Soriot not moving to Teva - Bloomberg - Globes
Teva Gets Generic Drugmakers' Backing in Bid to Redo Label Case - Bloomberg Law
How Uggs, Hoka, and Tevas Helped Build Deckers' $2.5 Billion Ugly-Shoe Empire - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
The Difficulties of Cloning a CEO - Bloomberg
13 Billionaire Phillip Frost Interview As Opko Health Inc Lists On Tel Aviv Stock Exchange Photos and Premium High Res Pictures - Getty Images
Teva CEO Says Drugmaker Will Fight U.S. Price-Fixing Charges
Teva CEO to Meet Netanyahu With Blunt Message on Need for Cuts - Bloomberg
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva (TEVA) Stock Plunges as CEO Kare Schultz Calls Bottom - Bloomberg
Teva Pharmaeutical Stock Gets Upgrade From Analyst | Barron's
Actavis CEO: Teva-Mylan deal could be "value-destroying" - גלובס
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva Pharmaceuticals - Wikipedia
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva Faces Securities Class Action Alleging Copaxone Kickbacks
Teva's Buffett Bump Fades After He Says Investment Wasn't His Idea - Bloomberg
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Teva Is Exploring Mylan Bid to Create Generic-Drug Giant - Bloomberg
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
